Facilitating adjustment to inflammatory bowel disease: A model of psychosocial intervention in non-psychiatric patients

Psychotherapy and Psychosomatics

Volumn 68, Issue 5, 1999, Pages 230-240

  Maunder, Robert ^a   Esplen, Mary Jane ^b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b NONE

Author keywords

Crohn's disease; Inflammatory bowel disease; Psychosocial intervention; Psychotherapy; Stress; Ulcerative colitis

Indexed keywords

ARTICLE; COPING BEHAVIOR; DISTRESS SYNDROME; EMOTIONALITY; ENTERITIS; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; PSYCHOTHERAPY; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; STRESS; ULCERATIVE COLITIS;

EID: 0032874579     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012339     Document Type: Article

References (97)

1. Gazzard BG, Price HL, Libby GW, Dawson AM: The social toll of Crohn's disease. Br Med J 1978;2:1117-1119.
2. Sørenson VZ, Olsen BG, Binder V: Life prospects and quality of life in patients with Crohn's disease. Gut 1987;28:382-385.
3. Joachim G, Milne B: Inflammatory bowel disease: Effects on lifestyle. J Adv Nurs 1987;12: 483-487.
4. Hendriksen C, Binder V: Social prognosis in patients with ulcerative colitis. Br Med J 1980; 281:581-583.
5. North CS, Alpers DH: A review of studies of psychiatric factors in Crohn's disease: Etiologic implications. Ann Clin Psychiatry 1994;6:117-124.
6. North CS, Clouse RE, Spitznagel EL, Alpers DH: The relation of ulcerative colitis to psychiatric factors: A review of findings and methods. Am J Psychiatry 1990;147:974-981.
7. Theis MK, Boyko EJ: Patient perceptions of causes of inflammatory bowel disease. Am J Gastroenterol 1994;89:1920.
8. Mast ME: Adult uncertainty in illness: A critical review of research. Sch Inq Nurs Pract 1995;9:3-24.
9. Druss RG: The Psychology of Illness; in Sickness and in Health. Washington, American Psychiatric Press, 1995.
10. Spira JL: Existential group therapy for advanced breast cancer and other life-threatening illnesses; in Spira JL (ed): Group Therapy for Medically III Patients. New York, Guilford Press, 1997.
11. Leserman J, Li Z, Yuming JB, Drossman DA: How multiple types of stressors impact on health. Psychosom Med 1998;60:175-181.
12. Fava GA, Pavan L: Large bowel disorders. I. Illness configuration and life events. Psychother Psychosom 1976;27:93-99.
13. Helzer JE, Stillings WA, Chammas S, Norland CC, Alpers DH: A controlled study of the association between ulcerative colitis and psychiatric diagnosis. Dig Dis Sci 1982;27:513-518.
14. Duffy LC, Zielezny MA, Marshall JR, Byers TE, Weiser MM, Phillips JF, Calkins BM, Ogra PL, Graham S: Relevance of major stress events as an indicator of disease activity prevalence in inflammatory bowel disease. Behav Med 1991;17:101-110.
15. Levenstein S, Prantera C, Varvo V, Seribano M, Berto E, Andreoli A: Psychological stress and disease activity in ulcerative colitis: A multidimensional cross-sectional study. Am J Gastroenterol 1994;89:1219-1225.
16. Moser G, Genser D, Tribl B, Vogelsang H: Psychological stress and disease activity in ulcerative colitis: A multidimensional cross-sectional study. Am J Gastroenterol 1995;90:1904.
17. Isgar B, Harman M, Kaye MD, Whorwell PJ: Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut 1983;24:190-192.
18. Collins SM, McHugh K, Jacobson K, Khan I, Riddell R, Murase K, Weingarten HP: Previous inflammation alters the response of the rat colon to stress. Gastroenterology 1996;111: 1509-1515.
19. Jacobson K, McHugh K, Collins S: The mechanism of altered neural function in a rat model of acute colitis. Gastroenterology 1997;112: 156-162.
20. Maunder RG, Cohen Z, McLeod RS, Greenberg G: Effect of intervention in inflammatory bowel disease on health-related quality of life: A critical review. Dis Colon Rectum 1995;38: 1147-1161.
21. Irvine EJ, Feagan B, Rochon J, Archambault A, Fedorak RN, Groll A, Kinnear D, Sabil F, McDonald JW: Quality of life: A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology 1994;106:287-296.
22. Guyatt G, Mitchell A, Irvine E, Singer J, Williams N, Goodacre R, Tompkins C: A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989;96:804-810.
23. Drossman DA, Patrick DL, Mitchell CM, Zagami EA, Appelbaum MI: Health-related quality of life in inflammatory bowel diseases: Functional status and patient worries and concerns. Dig Dis Sci 1989;34:1379-1386.
24. Drossman DA, Leserman J, Mitchell M, Li Z, Zagami EA, Patrick DL: Health status and health care use in persons with inflammatory bowel disease: A national sample. Dig Dis Sci 1991;36:1746-1755.
25. Levenstein S, Li Z, Drossman DA: Cross-cultural variation in disease-related concerns among patients with inflammatory bowel disease. Gastroenterology 1998;114:1021.
26. Maunder RG, De Rooy E, Toner B, Greenberg GR, Steinhart H, Baron D, McLeod R, Cohen Z: Health-related concerns of people who receive psychological support for inflammatory bowel disease. Can J Gastroenterol 1997;11: 681-685.
27. Mayberry MK, Probert C, Srivastava E, Rhodes J, Mayberry JF: Perceived discrimination in education and employment by people with Crohn's disease: A case control study of educational achievement and employment. Gut 1992:312-314.
28. Ferguson A, Sedgwick DM, Drummond J: Morbidity of juvenile onset inflammatory bowel disease: Effects on education and employment in early adult life. Gut 1994;35:665-668.
29. Wyke RJ: Capacity for work and employment record of patients with inflammatory bowel disease. Int Disabil Stud 1988;10:176-179.
30. Martinsson E, Josefsson M, Ek A: Working capacity and quality of life after undergoing an ileostomy. J Adv Nurs 1991;16:1035-1041.
31. Kinash RG, Fischer DG, Lukie BE, Carr TL: Coping patterns and related characteristics in patients with IBD. Rehabil Nurs 1993;18:12-19.
32. Aldwin CM: Stress, Coping and Development: An Integrative Perspective. New York, Guilford Press, 1994.
33. Folkman S, Lazarus RS: Ways of Coping Questionnaire Manual. Palo Alto, Mind Garden, 1988.
34. Maunder RG, Lancee WJ, Esplen MJ, Greenberg GR: Interim report on supportive-expressive group psychotherapy for inflammatory bowel disease. Psychosom Med 1998;60:127.
35. Broadhead WE, Kaplan BH, James SA, Wagner EH, Schoenbach VJ, Crimson R, Hoyden S, Tibblin G, Gehlbach SH: The epidemiologic evidence for a relationship between social support and health. Am J Epidemiol 1983;117: 521-537.
36. Biondi M, Zannino LG: Psychological stress, neuroimmunomodulation, and susceptibility to infectious diseases in animals and man: A review. Psychother Psychosom 1997;66:3-26.
37. Orth-Gomér K, Rosengren A, Wilhelmsen L: Lack of social support and incidence of coronary heart disease in middle-aged Swedish men. Psychosom Med 1993;55:37-43.
38. Levy SM, Herberman RB, Whitside T, Sanzo K, Lee J, Kirkwood J: Perceived social support and tumor estrogen/progesterone receptor states as predictors of natural killer cell activity in breast cancel patients. Psychosom Med 1990;52:73-85.
39. Theorell T, Blonihuist V, Jonsson H, Schulman S, Berntorp E, Stigendal L: Social support and the development of immune function in human immunodeficiency virus infection. Psychosom Med 1995;57:32-36.
40. Gerson MJ, Grega CH, Nathan-Verga S: Three kinds of coping: Families and inflammatory bowel disease. Family Syst Med 1993;11:55-65.
41. Engström I: Parental distress and social interaction in families of children with inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry 1991;30:904-912.
42. McMahon AW, Schmitt P, Patterson JF, Rothman E: Personality differences between inflammatory bowel disease patients and their healthy siblings. Psychosom Med 1973;35:91-103.
43. Engström I: Psychological problems in siblings of children and adolescents with inflammatory bowel disease. Eur Child Adolesc Psychiatry 1992;1:24-33.
44. Colcher SD: Family structure, stress, and individual adjustment to ulcerative colitis. Diss Abstr Int 1984;44:3200B.
45. Gloeckner MR: Partner reaction following ostomy surgery. J Sex Marital Ther 1983;9:182-190.
46. Hogan CC: Psychosomatics, Psychoanalysis and Inflammatory Disease of the Colon. Madison, International Universities Press, 1995.
47. Pettingale KW, Greer S, Tee DEH: Serum IgA and emotional expression in breast cancer patients. J Psychosom Res 1977;21:395-399.
48. Pennebaker JW, Kiecolt-Glaser J, Glaser R: Disclosure of traumas and immune function: Health implications for psychotherapy. J Consult Clin Psychol 1988;56:239-245.
49. Taylor GJ, Bagby RM, Parker JDA: The alexithymia construct: A potential paradigm for psychosomatic medicine. Psychosomatics 1991;32:153-164.
50. Fava GA, Pavan L: Large bowel disorders. II. Psychopathology and alexithymia. Psychother Psychosom 1976;27:100-105.
51. Taylor GJ, Doody K, Newman A: Alexithymic characteristics in patients with inflammatory bowel disease. Can J Psychiatry 1981;26:470-474.
52. Taylor GJ, Doody K: Verbal measures of alexithymia: What do they measure? Psychother Psychosom 1985;43:32-37.
53. Taylor GJ, Doody K: Psychopathology and verbal expression in psychosomatic and psychoneurotic patients. Psychother Psychosom 1982;38:121-127.
54. Porcelli P, Zaka S, Leoci C, Centonze S, Taylor GJ: Alexithymia in inflammatory bowel disease: A case-control study. Psychother Psychosom 1995;64:49-53.
55. Porcelli P, Leoci C, Guerra V, Taylor GJ, Bagby RM: A longitudinal study of alexithymia and psychological distress in inflammatory bowel disease. J Psychosom Res 1996;41:569-573.
56. Verissimo R, Mota-Cardoso R, Taylor G: Relationships between alexithymia, emotional control and quality of life in patients with inflammatory bowel disease. Psychother Psychosom 1998;67:75-80.
57. Lumley MA, Stettner L, Wehmer F: How are alexithymia and physical illness linked? A review and critique of pathways. J Psychosom Res 1996;41:505-518.
58. Taylor GJ, Bagby RM, Parker JDA: Disorders of Affect Regulation: Alexithymia in Medical and Psychiatric Illness. Cambridge, Cambridge University Press, 1997.
59. Dewaraja R, Tanigawa T, Araki S, Nakata A, Kawamura N, Ago Y, Sasaki Y: Decreased cytotoxic lymphocyte counts in alexithymia. Psychother Psychosom 1997;66:83-86.
60. Sifneos PE: Problems of psychotherapy of patients with alexithymic characteristics and physical disease. Psychother Psychosom 1975; 26:65-70.
61. Freyberger H, Künsebeck HW, Lempa W, Wellman W, Avenarius H-J: Psychotherapeutic interventions in alexithymic patients, with special regard to ulcerative colitis and Crohn patients. Psychother Psychosom 1985;44:72-81.
62. Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan: Dietary and other risk factors of ulcerative colitis: A case-control study in Japan. J Clin Gastroenterol 1994;19:166-171.
63. Godet PG, May GR, Sutherland LR: Metaanalysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut 1995;37: 668-673.
64. Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP: Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 1996;110:424-431.
65. Koutroubakis I, Manousos ON, Meuwissen SG, Pena AS: Environmental risk factors in inflammatory bowel disease. Hepatogastroenterology 1996;43:381-393.
66. Maunder RG, Cardish RJ: Psychological factors affecting medical condition: Prevalence and difficulty applying the diagnosis in inflammatory bowel disease. Psychosom Med 1996; 58:91.
67. Lindemann E: Psychiatric problems in the conservative treatment of ulcerative colitis. Arch Neurol Psychiatry 1945;53:322-324.
68. Groen J: Psychogenesis and psychotherapy of ulcerative colitis. Psychosom Med 1947;9:151-174.
69. Weinstock HI: Successful treatment of ulcerative colitis by psychoanalysis: A survey of 28 cases with follow-up. J Psychosom Res 1962;6: 243-249.
70. Schwarz SP, Blanchard EB: Inflammatory bowel disease: A review of the psychological assessment and treatment literature. Ann Behav Med 1990;12:95-105.
71. Joachim G: The effects of two stress management techniques on patients with IBD. Nurs Pap 1983;15:5-18.
72. Shaw L, Ehrlich A: Relaxation training as a treatment for chronic pain caused by ulcerative colitis. Pain 1987;29:287-293.
73. Milne B, Joachim G, Niedhardt J: A stress management programme for inflammatory bowel disease patients. J Adv Nurs 1986;11: 561-567.
74. Schwarz SP, Blanchard EB: Evaluation of a psychological treatment for inflammatory bowel disease. Behav Res Ther 1991;29:167-177.
75. Yalom ID: Existential Psychotherapy. New York, Basic Books, 1980.
76. Olbrisch ME, Ziegler SW: Psychological adjustment to inflammatory bowel disease: Informational control and private self-consciousness. J Chron Dis 1982;35:573-580.
77. Miller SM, Mangan CE: Interaction effects of information and coping style in adapting to gynaecologic stress: Should the doctor tell all? J Pers Soc Psychol 1983;45:223-226.
78. Taylor SE, Clark LF: Does information improve adjustment to noxious events? in Saks MJ, Saxe L (eds): Advances in Applied Social Psychology. Hillsdale, Erlbaum, 1986, vol 3.
79. Hodges B, Craven J, Littlefield C: Bibliotherapy for psychosocial distress in lung transplant patients and their families. Psychosomatics 1995;36:360-368.
80. Mayberry JF: Information booklets for patients with inflammatory bowel disease. Int Disabil Stud 1980;10:179-180.
81. Perez Silva R, Cervantes R, Romero M: A buddy project as a means to develop social networks for supporting people living with HIV/ AIDS (abstract No We.D.602). Int Conf AIDS 1996;11:54.
82. Matson JL, Zeiss RA: The buddy system: A method for generalized reduction of inappropriate interpersonal behaviour of retarded-psychiatric patients. Br J Soc Clin Psychol 1979; 18:401-405.
83. Rees JEP, Mayberry JF, Calcraft B: What the patient wants to know about Crohn's disease. J Clin Gastroenterol 1983;5:221-222.
84. Moskovitz D, Maunder R, Cohen Z, McLeod R, MacRae H: Coping and social support contribute independently to quality of life after surgery for IBD: Toward pro-surgical screening. Psychosom Med, in press.
85. Yalom I: The Theory and Practice of Group Psychotherapy, ed 4. New York, Basic Books. 1995.
86. Lieberman M, Borman L: Self-Help Groups for Coping with Crisis. San Fransisco, Josey-Bass, 1979.
87. Cable M: The role of patients' organizations. Int Disabil Stud 1980;10:181-182.
88. Greer S, Morris T, Pettingale KW: Psychological response to breast cancer: Effect on outcome. Lancet 1979;ii:785-787.
89. Marris P: Loss and Change. New York, Pantheon, 1974.
90. Bowlby J: Attachment and Loss. New York, Basic Books, 1980, vol 3: Loss: Sadness and Depression.
91. Bruning DJ: The effects of autogenic training on subjective stress levels, subjective symptoms and coping strategies in women with ulcerative colitis. Diss Abstr Int 1991;51:4774.
92. Baum CZ: Autogenic therapy as an adjunctive therapeutic modality in the treatment of Crohn's disease. Diss Abstr Int 1982;42:4567.
93. Hershfield NB, Kubryn W, Sutherland LR: Meditation training as adjunct therapy in the management of Crohn's disease: A pilot study. Can J Gastroenterol 1993;7:613-615.
94. Astin JA: Stress reduction through mindfulness meditation: Effects on psychological symptomatology, sense of control and spiritual experiences. Psychother Psychosom 1997;66:97-106.
95. Radnitz CL, Blanchard EB: Bowel sound biofeedback as a treatment for irritable bowel syndrome. Biofeedback Self Regul 1988;13:169-179.
96. Bassotti G, Whitehead WE: Biofeedback as a treatment approach to gastrointestinal tract disorders. Am J Gastroenterol 1994;89:158-164.
97. Spiegel D, Bloom JR, Kraemer HC, Gottheil E: Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989;ii:888-891.